Advisory Services Network’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-173
Closed -$21.1K 2671
2023
Q4
$21.1K Buy
+173
New +$13.2K ﹤0.01% 2499
2023
Q2
Sell
-105
Closed -$10.3K 2650
2023
Q1
$10.3K Buy
105
+65
+163% +$8.81K ﹤0.01% 2860
2022
Q4
$5.66K Buy
+40
New +$5.58K ﹤0.01% 3080
2021
Q3
Sell
-2
Closed -$3K 2417
2021
Q2
$3K Buy
+2
New +$2.77K ﹤0.01% 3220
2021
Q1
Sell
-1
Closed -$1K 2223
2020
Q4
$1K Buy
+1
New +$1.59K ﹤0.01% 3156

Other funds holding LABU

Advisory Services Network's LABU Position: Q1 2024 in Review

Advisory Services Network sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2024, closing a stake of 173 shares — an estimated $21.1K sold.

Advisory Services Network first reported a position in LABU in Q4 2020 and held it in 5 quarters. The position peaked at $21.1K in Q4 2023. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2024.

  • Advisory Services Network reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 173 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2024, an estimated $21.1K.
  • Advisory Services Network first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2020 and held it in 5 quarters.
  • Advisory Services Network's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $21.1K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.